Financials data is unavailable for this security.
View more
Year on year Avid Bioservices Inc 's revenues fell -6.27% from 149.27m to 139.91m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a gain of 259.00k to a loss of 140.75m.
Gross margin | 6.27% |
---|---|
Net profit margin | -101.27% |
Operating margin | -14.66% |
Return on assets | -37.08% |
---|---|
Return on equity | -115.84% |
Return on investment | -57.59% |
More ▼
Cash flow in USDView more
In 2024, Avid Bioservices Inc did not generate a significant amount of cash. Cash Flow from Financing totalled 20.07m or 14.34% of revenues. In addition the company generated 10.95m in cash from operations while cash used for investing totalled 31.81m.
Cash flow per share | -2.09 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.9192 |
---|---|
Tangible book value per share | 0.9192 |
More ▼
Balance sheet in USDView more
Current ratio | 1.46 |
---|---|
Quick ratio | 1.05 |
Total debt/total equity | 2.76 |
---|---|
Total debt/total capital | 0.7343 |
More ▼